first week semaglutide My dose of What to Expect After Your
Description
New obesity drugs are coming, including the 'triple agonist' Retatrutide (expected for approval in 2027), which activates 3 receptors: GLP1, GIP, and glucagon In a trial, Retatrutide caused loss of ~25% of bodyweight (in patients with obesity) in less than a year: New obesity drugs are coming, including the 'triple agonist' Retatrutide (expected for approval in 2027), which activates 3 receptors: GLP1, GIP, and glucagon In a trial, Retatrutide caused loss of ~25% of bodyweight (in patients with obesity) in less than a year:

Joe Hunstad in Charlotte, NC, uses liposuction to reduce the area of skin removal of fat before excision

Liraglutide (Saxenda): Helps control appetite and manage weight effectively

Blood orange juice inhibits fat accumulation in mice
